Home » Topics » BioWorld Science

BioWorld Science
RSS

ET-743 product overview and development update

Sep. 27, 1996

Japanese researchers report new antiangiogenic compound

Sep. 27, 1996

Antitumor lipid peroxidation inhibitor from Kirin Brewery

Sep. 27, 1996

Mitsubishi reports isolation of PI 3-kinase inhibitors

Sep. 27, 1996

Cel-Sci's Multikine to be tested clinically at additional centers

Sep. 27, 1996

Prostate cancer treatment approved by the FDA

Sep. 27, 1996

First localized treatment for fatal brain cancer approved by the FDA

Sep. 27, 1996

Joint venture to develop Biopharmaceutics' orphan anticancer drug

Sep. 27, 1996

Promising phase II results with vaccine for staph infections

Sep. 27, 1996

Clinical trial of an oral Campylobacter vaccine and adjuvant combination

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.